Abstract:This study aims to develop an in vitro barrier effect test over biomimetic membrane, which is useful to establish the film forming ability of a substance-based medical device (SB-MD). The method contemplates a multiparametric approach including: i ) the measurement of the transmembrane passage of a molecular-like marker over a lipid-impregnated biomimetic membrane (simulating the skin and gastro-intestinal and buccal tissues) by using a static diffusion cell apparatus (Franz cell); and ii ) the evaluation of the integrity of the membrane (colorimetric test). In the first step, a series of lipid-impregnated biomimetic membranes (simulating gastro-intestinal, buccal, and skin tissues) were implemented and their permeability performance validated using model drugs (caffeine and acyclovir) by referring to literature data. As a result, the apparent permeability (P app ) of caffeine over the biomimetic gastro-intestinal membrane (P app = 30.5E-6 cm/s) was roughly comparable to the literature values obtained with Caco-2 cell line membrane (P app = 30.8E-6 cm/s) and with the Franz cell method (P app = 36.2E-6 cm/s). Acyclovir was shown to be a poorly permeable substance both in the literature and experimental data. Following this step, the permeability study was extended to both biomimetic buccal and skin (STRAT-M ® ) membranes: for caffeine, biomimetic gastro-intestinal membrane was the most permeable (P app = 30.5E-6 cm/s), followed by the buccal (P app = 18.2E-6 cm/s) then the skin (P app = 0.5E-6 cm/s) biomimetic membranes. In a second part of the work, the barrier effect test was developed following a similar permeability-like approach. The protocol was designed with the idea of assessing the capacity of a certain product to prevent the passage of caffeine across the biomimetic membrane with respect to a negative and positive control. The untreated membrane was the negative control, while membrane covered with a Vaseline film was the positive. As a last step, the developed barrier effect protocol was applied to an experimental gel-like SB-MD under development for the treatment of aphthae (Aphthae gel, an invented trade name), herein used as a case study. Regarding the results, Aphthae gel reduced the caffeine passage by 60.3%, thus highlighting its effectiveness to form a protective film. Overall, these results provide important knowledge and may pave the way for the use—including for industrial applications—of these simple but effective biomimetic membranes for carrying out high throughput screening necessary to design safe and effective SB-MDs before proceeding further with clinical trials, as requested by the regulations.

Engineering and validation of a novel lipid thin film for biomembrane modeling in lipophilicity determination of drugs and xenobiotics

Structures, Dynamics, and Water Permeation Free Energy Across Bilayers of Lipid A and Its Analog Studied with Molecular Dynamics Simulation

Lipid Microfluidic Biomimetic Models for Drug Screening: A Comprehensive Review

Membrane-Mimicking Reverse Micelles for High-Resolution Interfacial Study of Proteins and Membranes

Unravelling the interactions between small molecules and liposomal bilayers via molecular dynamics and thermodynamic modelling

Liposomes as biomembrane models: Biophysical techniques for drug-membrane interaction studies

Experimental validation of a phase-field model to predict coarsening dynamics of lipid domains in multicomponent membranes

Formation of sparsely tethered bilayer lipid membrane on a biodegradable self-assembled monolayer of poly(lactic acid)

Sorting and Screening of Quaternary Ammonium Lipoids for Membrane-Binding Assays Based on Electrochemiluminescent Cocrystalline Nanosheets

Lipid Biomimetic Models as Simple Yet Complex Tools to Predict Skin Permeation and Drug–Membrane Biophysical Interactions

Structural Analysis of A Nanoparticle Containing A Lipid Bilayer Used for Detergent-Free Extraction of Membrane Proteins

Suitability of Artificial Membranes in Lipolysis-Permeation Assays of Oral Lipid-Based Formulations

Safety and efficacy of substance-based medical devices: Design of an in vitro barrier effect test

A Novel Mixed Phospholipid Functionalized Monolithic Column for Early Screening of Drug Induced Phospholipidosis Risk

Preparation of supported lipid bilayer membranes by thin film extrusion

Modeling of small molecule's affinity to phospholipids using IAM-HPLC and QSRR approach enhanced by similarity-based machine algorithms

Modeling of a biphasic membrane reactor catalyzed by lipase immobilized in a hydrophilic/hydrophobic composite membrane

The Development of an Artificial Skin Membrane Mimicking the Lipid Bilayer Structure for in Vitro Permeation Study

Immobilised artificial membrane liquid chromatography vs liposome electrokinetic capillary chromatography: Suitability in drug/bio membrane partitioning studies and effectiveness in the assessment of the passage of drugs through the respiratory mucosa

A Membrane-Mimetic Barrier for Cell Encapsulation

Engineering phosphatidylinositol-4,5-bisphosphate model membranes enriched in endocytic cargo: A neutron reflectometry, AFM and QCM-D structural study